牛传染性鼻气管炎基因工程疫苗研究进展

摘要/Abstract

摘要： 牛传染性鼻气管炎是由牛疱疹病毒1型感染而引起的高传染性疾病。该病临床症状以呼吸道炎症为主,另外伴有结膜炎、流产、脑炎等并发症。20世纪50年代早期,美国科罗拉多州某些牧场首次发现该病。目前缺乏有效的治疗性药物,对动物实施疫苗免疫是防控该病较理想的方法。目前,某些国家仍然使用传统疫苗,然而,经过基因改造的糖蛋白E基因缺失疫苗已在欧盟上市,该疫苗分为活苗和灭活苗两种。文章着重对牛传染性鼻气管炎基因缺失疫苗、亚单位疫苗、活载体疫苗及DNA疫苗最新的研究进行评述。

关键词: 牛传染性鼻气管炎; 基因缺失疫苗; 亚单位疫苗; 活载体疫苗; DNA疫苗

Abstract: Infectious bovine rhinotracheitis (IBR) is a highly contagious, infectious disease that is caused by bovine herpes-virus-1(BHV-1). In addition to causing respiratory disease, this virus can cause conjunctivitis, abortions, encephalitis, andgeneralized systemic infections. IBR was originally recognized during the early 1950’s in Colorado feedlots. There is no direct treatment for the infection and the best way to control IBR is to vaccinate before a disease outbreak occurs. Nowadays, conventional IBR vaccines have been, and still are, routinely used in many countries, the glycoprotein E (gE)-deleted vaccines, either as a live or as a inactivated vaccine, have been commercialized in the European Union. In this review, we discussed the progress in development of gene-deleted vaccine, subunit vaccine, viral vector vaccine and DNA vaccine.

Key words: infectious bovine rhinotracheitis; gene-deleted vaccine; subunit vaccine; viral vector vaccine; DNA vaccine

中图分类号:

S859.79

徐琼, 何宇乾, 吴海燕. 牛传染性鼻气管炎基因工程疫苗研究进展[J]. , 2012, 39(11): 52-56.

XU Qiong, HE Yu-qian, WU Hai-yan. Progress in Development of Genetic Engineering Vaccines against Infectious Bovine Rhinotracheitis[J]. , 2012, 39(11): 52-56.

参考文献

1 李长友, 秦德超, 肖肖. 一二三类动物疫病释义[M]. 北京: 中国农业出版社, 2011.
2 Abdelmagid O Y, Mansour M M, Okwumabua O, et al. Expression and cellular distribution of baculovirus-expressed bovine herpesvirus 1 (BHV-1) glycoprotein D (gD) sequences[J]. Archives of Virology, 1998, 143 (11): 2173~2187.
3 Bosch J C, Kaashoek M J, Kroese A H, et al. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines[J]. Veterinary Microbiology, 1996, 52 (3~4): 223~234.
4 Braun R P, Babiuk L A, Loehr B I, et al. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1[J]. Virology, 1999, 265 (1): 46~56.
5 Chase C C, Carter-Allen K, Lohff C, et al. Bovine cells expressing bovine herpesvirus 1 (BHV-1) glycoprotein Ⅳ resist infection by BHV-1, herpes simplex virus, and pseudorabies virus[J]. Journal of Virology, 1990, 64 (10): 4866~4872.
6 Cox G J, Zamb T J, Babiuk L A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA[J]. Journal of Virology, 1993, 67 (9): 5664~5667.
7 Denis M, Hanon E, Rijsewijk F A, et al. The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1[J]. Veterinary Microbiology, 1996, 53 (1~2): 121~132.
8 Dispas M, Schynts F, Lemaire M, et al. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field[J]. Veterinary Record, 2003, 153 (7): 209~212.
9 Ferrer M F, Del Medico Zajac M P, Zanetti F A, et al. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models[J]. Viral Immunology, 2011, 24 (4): 331~339.
10 Gogev S, de Fays K, Versali M F, et al. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1[J]. Vaccine, 2004, 22 (15~16): 1946~1953.
11 Ioannou X P, Griebel P, Hecker R, et al. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen are increased by formulation with CpG oligodeoxynucleotides[J]. Journal of Virology, 2002, 76 (18): 9002~9010.
12 Kaashoek M J, Rijsewijk F A, Ruuls R C, et al. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene[J]. Vaccine, 1998, 16 (8): 802~809.
13 Khattar S K, Collins P L, Samal S K. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1[J]. Vaccine, 2010, 28 (18): 3159~3170.
14 Langellotti C A, Pappalardo J S, Quattrocchi V, et al. Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants[J]. Antiviral Research, 2011, 90 (3): 134~142.
15 Lemaire M, Schynts F, Meyer G, et al. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: Influence of virus load and effect of specific maternal antibodies[J]. Vaccine, 2001, 19 (32): 4795~4804.
16 Makoschey B, Franken P, Mars J M, et al. IBR and BVD control: The key to successful herd management[J]. Berliner und Munchener Tierarztliche Wochenschrift, 2010, 123 (11~12): 516~518, 519~521.
17 Mars M H, de Jong M C, Franken P, et al. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field[J]. Vaccine, 2001, 19 (15~16): 1924~1930.
18 Miller N J. Infectious necrotic rhinotracheitis of cattle[J]. Journal of the American Veterinary Medical Association, 1955, 126 (939): 463~467.
19 Petrini S, Ramadori G, Corradi A, et al. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves[J]. Comparative Immunology, Microbiology and Infectious Diseases, 2011, 34 (1): 3~10.
20 Rijsewijk F A, Kaashoek M J, Langeveld J P, et al. Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains[J]. Archives of Virology, 2000, 145 (5): 921~936.
21 Robinson K E, Meers J, Gravel J L, et al. The essential and non-essential genes of bovine herpesvirus 1[J]. Journal of General Virology, 2008, 89 (Pt 11): 2851~2863.
22 van Donkersgoed J, McCartney D, van Drunen Littel-van den Hurk S. Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol[J]. Canadian Journal of Veterinary Research, 1996, 60 (1): 55~58.
23 van Drunen Littel-van den Hurk S, Parker M D, Massie B, et al. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV[J]. Vaccine, 1993, 11 (1): 25~35.
24 van Drunen Littel-van den Hurk S, Snider M, Thompson P, et al. Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies[J]. Vaccine, 2008, 26 (25): 3103~3111.
25 van Engelenburg F A, Kaashoek M J, Rijsewijk F A, et al. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves[J]. Journal of General Virology, 1994, 75 (Pt 9): 2311~2318.
26 van Oirschot J T. Diva vaccines that reduce virus transmission[J]. Journal of Biotechnology, 1999, 73 (2~3): 195~205.
27 Zakhartchouk A N, Pyne C, Mutwiri G K, et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: Induction of protective immunity to bovine herpesvirus-1[J]. Journal of General Virology, 1999, 80 (5): 1263~1269.
28 Zhu X, Letchworth G J. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle[J]. Vaccine, 1996, 14 (1): 61~69.
29 Zhu X, Wu S, Letchworth G J. Yeast-secreted bovine herpesvirus type 1 glycoprotein D has authentic conformational structure and immunogenicity[J]. Vaccine, 1997, 15 (6~7): 679~688.

[1]	赵逢淼, 郭婷, 周雅坪, 赵红梅, 王宇琛, 田广原, 孙雅婕, 卞宇晨, 于佳梁, 郝永清. 牛病毒性腹泻病毒对新西兰白兔致病性分析及E2蛋白免疫效果的评价[J]. 中国畜牧兽医, 2022, 49(9): 3549-3558.
[2]	杨明珠, 陈晓春, 宋佳诚, 侯亚欣, 李俊平. 重组动物疱疹病毒活载体疫苗的构建与应用研究进展[J]. 中国畜牧兽医, 2022, 49(1): 338-351.
[3]	潘晨浩, 张欣, 赵瑞利, 姜轩, 金天明, 于恩远, 李留安, 曾君, 于晓雪, 宋淇淇, 胡烨. 猪链球菌重组靶向表位蛋白DCpep-GSE的构建及细胞毒性检测[J]. 中国畜牧兽医, 2021, 48(8): 2990-3001.
[4]	朱伟峰, 陈露, 王芳, 胡波, 阮智杨, 王高杰. 巴氏杆菌糖酵解酶的免疫保护效应研究[J]. 中国畜牧兽医, 2021, 48(6): 2188-2195.
[5]	许学林, 杨波, 荆焕松, 胡映红, 王风华, 孙培皓, 熊家军. 双表达去势DNA疫苗的构建及其稳定性研究[J]. 中国畜牧兽医, 2021, 48(5): 1745-1754.
[6]	杨帅, 张欣欣, 周迪, 袁婧, 杨利国. 生长抑素和皮质抑素双表达DNA疫苗免疫杂交水牛育成牛的促生长效果研究[J]. 中国畜牧兽医, 2021, 48(4): 1361-1369.
[7]	王宁, 赵鹏鹏, 张艳艳, 马勋, 王正荣, 薄新文. 寄生虫DNA疫苗研究进展[J]. 中国畜牧兽医, 2021, 48(3): 1034-1045.
[8]	冯亚亚, 郭晶, 李玉保, 刘成, 李旭勇. 禽流感DNA疫苗研究进展[J]. 中国畜牧兽医, 2020, 47(11): 3667-3675.
[9]	兰德松, 顾贵波, 侯振中. 伪狂犬病病毒野毒株与gE基因缺失疫苗株TaqMan实时荧光定量PCR鉴别方法的建立[J]. 《中国畜牧兽医》, 2018, 45(7): 1804-1812.
[10]	季文恒, 吴娅琴, 翟肖辉, 储岳峰. 牛支原体疫苗的研究进展[J]. 《中国畜牧兽医》, 2018, 45(3): 763-769.
[11]	吴靖, 许健, 黄秀芬, 沈俊俊, 何后军, 李永清. 抗牛传染性鼻气管炎病毒囊膜gD糖蛋白的单链抗体在昆虫细胞中表达及活性检测[J]. 《中国畜牧兽医》, 2017, 44(8): 2475-2482.
[12]	王立波, 吴润生, 闫超, 吕暾. 不同佐剂对猪圆环病毒衣壳蛋白免疫原性的影响[J]. 《中国畜牧兽医》, 2016, 43(11): 3037-3046.
[13]	吴植, 郝福星, 王永娟, 刘洋, 王栋, 徐州, 袁维峰. 特异性靶向犬细小病毒融合DNA疫苗的构建及免疫效果的研究[J]. 《中国畜牧兽医》, 2016, 43(10): 2768-2774.
[14]	张凯照, 于梦, 宁章勇. 羊口疮病毒活载体疫苗和生物制剂的研制现状[J]. 《中国畜牧兽医》---唯一指定的官方网站, 2015, 42(9): 2499-2505.
[15]	赵雪丽, 闫若潜, 吴志明, 曹伟伟, 王淑娟, 谢彩华, 马震原, 周兵强, 王东方. 鉴别猪伪狂犬病病毒gE基因缺失疫苗和野毒感染的二重PCR诊断方法的建立和应用[J]. , 2015, 42(4): 865-870.